Insulin aspart, recombinant Subcutaneous and Telotristat Etiprate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Telotristat Etiprate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: telotristat
Brand name: Xermelo
Synonyms: Telotristat ethyl, Telotristat Ethyl
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Temazepam
- Insulin aspart, recombinant Subcutaneous-Temixys
- Insulin aspart, recombinant Subcutaneous-Temodar
- Insulin aspart, recombinant Subcutaneous-Temodar (Temozolomide Capsules)
- Insulin aspart, recombinant Subcutaneous-Temodar (Temozolomide Injection)
- Insulin aspart, recombinant Subcutaneous-Temodar Intravenous
- Telotristat Etiprate-Insulin degludec
- Telotristat Etiprate-Insulin Degludec (U-100) Prefilled Pens
- Telotristat Etiprate-Insulin Degludec (U-100) Vials
- Telotristat Etiprate-Insulin Degludec (U-200) Prefilled Pens
- Telotristat Etiprate-Insulin degludec and liraglutide
- Telotristat Etiprate-Insulin degludec and liraglutide Subcutaneous